Lack of Annexin A1 Exacerbates Inflammatory Response in Acute Endometritis Model.

Inflammation

Department of Morphology and Genetics, Universidade Federal de São Paulo, Rua Botucatu 740, Edifício Lemos Torres - 3° andar, São Paulo, SP, 04023-900, Brazil.

Published: June 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Annexin A1 (AnxA1) is a glucocorticoid-inducible protein and an important endogenous modulator of inflammation. However, its effect in the endometrial microenvironment is poorly explained. This study aimed to evaluate the role of endogenous AnxA1 in an endometritis mouse model induced by lipopolysaccharide (LPS). Female C57BL/6 wild-type (WT) and AnxA1 mice were divided into two groups: SHAM and LPS. To induce endometritis, mice received a vaginal infusion of 50 μL of LPS (1 mg/mL) dissolved in phosphate-buffered saline. After 24 h, the mice were euthanized, and blood and uteri samples were collected. The endometrium inflammatory scores were significantly increased in the LPS-treated group. AnxA1 mice from the LPS group demonstrated a significant increase in the number of degranulated mast cell levels compared to AnxA1 SHAM mice. The Western blotting analysis revealed that a lack of AnxA1 promoted the upregulation of NLRP3 and pro-IL-1β in the acute endometritis animal model compared to WT LPS animals. LPS-induced endometritis increased the number of blood peripheral leukocytes in both WT and AnxA1 mice compared with SHAM group mice (p < 0.001). AnxA1 mice also showed increased plasma levels of IL-1β (p < 0.01), IL-6, IL-10, IL-17, and TNF-α (p < 0.05) following LPS-induced endometritis. In conclusion, a lack of endogenous AnxA1 exacerbated the inflammatory response in an endometritis model via NLRP3 dysregulation, increased uterine mast cell activation, and plasma pro-inflammatory cytokine release.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10753-023-01959-3DOI Listing

Publication Analysis

Top Keywords

anxa1 mice
16
anxa1
9
inflammatory response
8
acute endometritis
8
endometritis model
8
endogenous anxa1
8
mice
8
mast cell
8
lps-induced endometritis
8
endometritis
7

Similar Publications

Objective: This preclinical study investigates a novel targeted collagen type IV nanoparticle formulation, Ac2-26 coated with chitosan and pectin ((pc)-Col-IV-Ac2-26-NPs), to promote anastomotic healing in a model of acute Crohn's disease (CD) with distal colo-colonic anastomosis, using intraperitoneal, oral and rectal delivery to optimize therapeutic effects while minimizing systemic immunosuppression.

Summary Background Data: Surgery remains critical for CD-patients due to irreversible tissue damage, with anti-inflammatory therapies increasing the risk of postoperative complications like anastomotic leaks.

Method: Female BALB/c mice (n=152) with CD-like colitis (2,4,6-Trinitrobenzenesulfonic acid) were randomized to receive (pc)-Col-IV-Ac2-26-NPs or scrambled NPs intraperitoneally, orally, or rectally every 3.

View Article and Find Full Text PDF

Annexin-A1 (ANXA1) participates in regulating ferroptosis. Ferroptosis is involved in myocardial ischemia-reperfusion injury (MIRI). However, effect and mechanism of ANXA1 in ferroptosis after MIRI remain unclear.

View Article and Find Full Text PDF

Pro-inflammatory regulation of EGFR-Annexin A2 synergy by sodium butyrate: An upstream target to reduce articular inflammation and cartilage destruction in rheumatoid arthritis.

Cytokine

October 2025

NITTE (Deemed to be University), Central Research Laboratory, K.S. Hegde Medical Academy, Deralakatte, Mangalore 575018, Karnataka, India; NITTE (Deemed to be University), Department of Biochemistry, K.S. Hegde Medical Academy, Deralakatte, Mangalore 575018, Karnataka, India. Electronic address: pra

Rheumatoid arthritis (RA) is a debilitating autoimmune disease characterized by persistent articular inflammation and joint damage. Our prior research identified a pro-inflammatory interplay between the epidermal growth factor receptor (EGFR) and Annexin A2 (AnxA2), which is exacerbated by Annexin A1 (AnxA1) downregulation in RA pathogenesis. The present study elucidates the immunomodulatory potential of sodium butyrate, a gut microbiota-derived short-chain fatty acid, in disrupting the EGFR-AnxA2 axis and restoring AnxA1 homeostasis.

View Article and Find Full Text PDF

Trimethylamine N-Oxide Mitigates Perioperative Neurocognitive Disorders via ANXA1 Nuclear Translocation and M2 Microglial Polarization in the Hippocampus.

CNS Neurosci Ther

August 2025

Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Aims: This study investigates whether trimethylamine N-oxide (TMAO) mitigates perioperative neurocognitive disorders (PND) by modulating Annexin A1 (ANXA1) and microglial polarization, thereby reducing neuroinflammation in the hippocampus.

Methods: A murine PND model was established via tibial fracture surgery under sevoflurane anesthesia. Mice were pretreated with TMAO (1.

View Article and Find Full Text PDF

This study aimed to investigate the therapeutic potential of annexin A1 (ANXA1) overexpression in improving the signs of dry eye disease (DED) and to elucidate the underlying molecular mechanism. A murine model of DED was established by topical application of 0.2% benzalkonium chloride (BAC), and human corneal epithelial (HCE-T) cells were exposed to 0.

View Article and Find Full Text PDF